Private limited company · Lillestrøm
ONCOGENE AS
ActiveTechnical testing and analysis (71.200)
The life line 2020–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 1.2m.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
ONCOGENE AS is a private limited company in Lillestrøm, founded in 2020, in the industry technical testing and analysis. The chief executive is Morten Bjelke-Holtermann Duesund, and the chair of the board is Morten Bjelke-Holtermann Duesund. In 2025 the company had NOK 1.2m in operating revenue and a net profit of NOK −2.3m. The largest owner is MODUS I AS with 72.0%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 14 Oct 2026
- Registered as an employer
- No longer registered as an employer
- Annual accounts filed 2024 → 2025
- Kapital
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
None registered
None of the rules apply.The rules are fixed: bankruptcy, missing annual accounts, three years of losses, negative equity and the like. Checked 15 Nov 2026.
Overview
§ 03 Key figures
Revenue NOK 1.2m in 2025
Revenue
NOK 1.2m
+85.4% from 2024
20232025
Operating profit
NOK −2.1m
−1,155.3% from 2024
20232025
Net profit
NOK −2.3m
−4,145.5% from 2024
20232025
Equity
NOK 32k
−97.1% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 114%
- Depreciation 43%
- Other operating costs 113%
- Not specified in the source 8%
Costs exceeded revenue: the operating result was NOK −2.1m.
Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 0.5%
- ONCOGENE AS, 2025
- Industry median, assumed: NOK 2.7m · 6.6% · 50.9% · +4.4%
Equity NOK 32k1% of the assets (NOK 5.9m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 340 companies in 71.200 Technical testing and analysis, not stated by the source.
Finances
§ 06 Accounts
5 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 1,194 | 644 | — | |
| Operating profit | −2,122 | 201 | −46 | |
| Profit before tax | −2,309 | 57 | −46 | |
| Net profit | −2,309 | 57 | −46 | |
| Total assets | 5,938 | 7,521 | 1,330 | |
| Equity | 32 | 1,101 | 37 | |
| Liabilities | 5,906 | 6,420 | 1,294 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 5 years →
Management and ownership
§ 07 Officers
5 officers now
- REGNSKAP.DIGITAL ASAccountant
- Morten Bjelke-Holtermann DuesundChief executive since 2024
- Morten Bjelke-Holtermann DuesundChair of the board since 2023
- Ida Christine Filtenborg HansenBoard member since 2024
- Tore Helge RismyhrBoard member since 2024
Source: the Brønnøysund Register Centre, read 22 Oct 2026 · All 6 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
None registered
No signature or procuration registered.The Register of Business Enterprises has no provision for the company. Checked 15 Nov 2026.
Management and ownership
§ 09 Owners
3 shareholders · largest 72.0%
| Owner | Share |
|---|---|
| MODUS I AS | 72.0% |
| ECONTO AS | 10.0% |
| MAKRI INVEST AS | 5.0% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 3 owners →
Management and ownership
§ 10 Group
None registered
Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
19 connections
- Person
- Company
3 people link ONCOGENE AS to 12 other companies: Morten Bjelke-Holtermann Duesund 7, Ida Christine Filtenborg Hansen 4 and Tore Helge Rismyhr 1.
Source: the Brønnøysund Register Centre, read 22 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
17 since 2020
Events per year
20202026
Since 2020: 12 announcements, 3 register changes and 2 new and 0 former owners. Most happened in 2024 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 15 Nov 2026. Register changes are Intelligo's own observations. · All 17 events →
Events and registers
§ 14 Notices
12, latest 28 Apr 2026
- Kapital
- Vedtektsdato
- Godkjente årsregnskap
Source: The Brønnøysund Register Centre's announcements ↗, read 15 Nov 2026 · All 12 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 21 Oct 2020
- VATRegistered
- The Register of Business EnterprisesRegistered 21 Oct 2020
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Tilby genetiske analyser for privatpersoner, forskning og annen næringsvirksomhet, samt bioinformatikk analyse av alle slag for presisjonsmedisin og personalisert terapi, og annet som naturlig faller sammen med dette.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 71.200
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
5 questions
- Who is the chief executive of ONCOGENE AS?
Morten Bjelke-Holtermann Duesund, since 2024. § 07 - Who owns ONCOGENE AS?
3 shareholders. The largest is MODUS I AS with 72.0%, ECONTO AS with 10.0% and MAKRI INVEST AS with 5.0%. § 09 - What was the revenue in 2025?
NOK 1.2m in the company. § 06 - Where is ONCOGENE AS based?
Gunnar Randers' vei 12, 2007 Kjeller. - When was ONCOGENE AS founded?
29 Sep 2020, registered in the Register of Business Enterprises 21 Oct 2020. § 16
The answers come from the sections linked to, with their sources.